US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class I · High risk Terminated

Thumbs up 7 Red 70K capsules

Reason Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Ummzy, LLC D-0664-2021
Class I · High risk Terminated

Shogun-X capsules

Reason Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Ummzy, LLC D-0663-2021
Class I · High risk Terminated

Krazy Night capsule

Reason Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Ummzy, LLC D-0662-2021
Class II · Moderate risk Ongoing

Triple SupremeZen Gold 3500

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

Na Na Collection D-0354-2021
Class II · Moderate risk Ongoing

PremierZen Platinum 5000

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

Na Na Collection D-0353-2021
Class I · High risk Ongoing

69MODE Blue 69 capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making it an unapproved drug for which the safety and efficacy have not been established and therefore subject to recall.

Nuri Trading LLC D-0688-2021
Class I · High risk Ongoing

Thumbs Up 7 White 11K capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil sildenafil, and vardenafil, FDA approved drugs making them an unapproved drug for which the safety and efficacy have not been established and therefore subject to recall.

Nuri Trading LLC D-0687-2021
Class I · High risk Ongoing

Thumbs Up 7 Black 25K capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil, an FDA approved drug making this an unapproved drug for which the safety and efficacy has not been established and therefore subject to recall.

Nuri Trading LLC D-0686-2021
Class I · High risk Ongoing

Shogun-X 7000 capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Nuri Trading LLC D-0685-2021
Class II · Moderate risk Terminated

Antiseptic Hand Cleaner

Reason CGMP Deviations

Spartan Chemical Co Inc D-0361-2021
Class I · High risk Terminated

Lite'n Foamy Lemon Blossom Hand Sanitizer

Reason Microbial Contamination of Non-Sterile Products; lot tested positive for Bulkholderia multivorans

Spartan Chemical Co Inc D-0359-2021
Class III · Low risk Terminated

Lidocaine Ointment USP

Reason Failed Stability Specifications: product did not meet viscosity results.

Teligent Pharma, Inc. NDC 52565-008-14 D-0331-2021
Class II · Moderate risk Terminated

Thumbs Up 7 Red 70K

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.

Antoto-K D-0366-2021
Class II · Moderate risk Terminated

Cefprozil for Oral Suspension USP

Reason Superpotent Drug

Lupin Pharmaceuticals Inc. NDC 68180-402-01 D-0332-2021
Class II · Moderate risk Ongoing

Imperial Extreme 2000 Capsules

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.

S & B Story LLC D-0352-2021
Class II · Moderate risk Terminated

PremierZen Black 5000 capsules

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.

Namoo Enterprise LLC D-0351-2021
Class III · Low risk Terminated

Metformin HCl Extended-Release Tablets

Reason Failed Moisture Limits: Out of specification for water content

Sun Pharmaceutical Industries INC NDC 62756-142-02 D-0325-2021
Class II · Moderate risk Terminated

Thumbs Up 7 Blue 69K

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.

Bit & Bet LLC D-0388-2021
Class I · High risk Terminated

Xultophy 100/3.6

Reason Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Novo Nordisk Inc NDC 0169-2911-90 D-0623-2021
Class II · Moderate risk Terminated

ViCTOZA

Reason Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Novo Nordisk Inc NDC 0169-4060-90 D-0622-2021